WallStreetZenWallStreetZen

NASDAQ: NVAX
Novavax Inc Stock

Open Broker Account
$21.00-1.44 (-6.42%)
Updated Sep 23, 2022
NVAX Price
$21.00
Fair Value Price
$38.60
Market Cap
$1.64B
52 Week Low
$20.46
52 Week High
$249.04
P/E
-1.08x
P/B
-3.94x
P/S
3.11x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.29B
Earnings
-$1.48B
Gross Margin
77.8%
Operating Margin
-110.59%
Profit Margin
-114.3%
Debt to Equity
-7.29
Operating Cash Flow
-$744M
Beta
1.11
Next Earnings
Nov 2, 2022
Ex-Dividend
N/A
Next Dividend
N/A

NVAX Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NVAX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NVAX ($21.00) is undervalued by 45.6% relative to our estimate of its Fair Value price of $38.60 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
NVAX ($21.00) is significantly undervalued by 45.6% relative to our estimate of its Fair Value price of $38.60 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
NVAX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NVAX due diligence checks available for Premium users.

Be the first to know about important NVAX news, forecast changes, insider trades & much more!

NVAX News

Valuation

NVAX fair value

Fair Value of NVAX stock based on Discounted Cash Flow (DCF)
Price
$21.00
Fair Value
$38.60
Undervalued by
45.60%
NVAX ($21.00) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NVAX ($21.00) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NVAX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NVAX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.08x
Industry
15.88x
Market
27.65x

NVAX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-3.94x
Industry
4.31x

NVAX's financial health

Profit margin

Revenue
$185.9M
Net Income
-$510.5M
Profit Margin
-274.6%
NVAX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NVAX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.6B
Liabilities
$3.0B
Debt to equity
-7.29
NVAX's short-term liabilities ($2.16B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NVAX's short-term assets ($2.14B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NVAX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NVAX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$170.9M
Investing
-$24.6M
Financing
$4.7M
NVAX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NVAX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
NVAX$1.64B-6.42%-1.08x-3.94x
AMLX$1.63B-4.39%N/A8.46x
RVMD$1.62B+0.11%-6.06x3.24x
MYOV$1.61B-3.50%-9.56x-3.34x
SAVA$1.68B-18.00%-27.55x7.69x

Novavax Stock FAQ

What is Novavax's quote symbol?

NASDAQ: NVAX) Novavax trades on the NASDAQ under the ticker symbol NVAX. Novavax stock quotes can also be displayed as NASDAQ: NVAX.

If you're new to stock investing, here's how to buy Novavax stock.

What is the 52 week high and low for Novavax (NASDAQ: NVAX)?

(NASDAQ: NVAX) Novavax's 52-week high was $249.04, and its 52-week low was $20.46. It is currently -91.57% from its 52-week high and 2.64% from its 52-week low.

How much is Novavax stock worth today?

(NASDAQ: NVAX) Novavax currently has 78,215,105 outstanding shares. With Novavax stock trading at $21.00 per share, the total value of Novavax stock (market capitalization) is $1.64B.

Novavax stock was originally listed at a price of $100.00 in Dec 31, 1997. If you had invested in Novavax stock at $100.00, your return over the last 24 years would have been -79%, for an annualized return of -6.3% (not including any dividends or dividend reinvestments).

How much is Novavax's stock price per share?

(NASDAQ: NVAX) Novavax stock price per share is $21.00 today (as of Sep 23, 2022).

What is Novavax's Market Cap?

(NASDAQ: NVAX) Novavax's market cap is $1.64B, as of Sep 27, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Novavax's market cap is calculated by multiplying NVAX's current stock price of $21.00 by NVAX's total outstanding shares of 78,215,105.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.